MiMedx outlines $250M-$260M 2026 net sales as it targets >20% adjusted EBITDA margin with Sanara
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.